Champions Oncology, Inc. (CSBR) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -1.34M | -1.74M | 600K | 6.87M | 490K | -283K | 311K | -1.82M | -919K | 589K | -3.99M | -692K |
| Operating CF Margin % | - | -11.54% | 4.29% | 55.59% | 2.88% | -2.1% | 2.21% | -12.97% | -7.65% | 5.09% | -31.77% | -5.29% |
| Operating CF Growth % | -373.27% | -513.07% | 92.93% | 478.19% | 153.32% | -148.05% | 107.79% | -162.43% | -158.42% | -82.08% | -1946.67% | -186.93% |
| Net Income | -278K | 236K | -466K | -1.83M | 4.5M | 728K | 1.31M | -109K | -2.53M | -2.07M | -2.57M | -2.56M |
| Depreciation & Amortization | 341K | 357K | 358K | 394K | 398K | 399K | 449K | 457K | 1.26M | 484K | 445K | 583K |
| Stock-Based Compensation | 423K | 249K | 208K | 131K | 256K | 9K | 258K | 263K | 379K | 53K | 423K | 208K |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.04M | -1.34M | 137K | 162K | 919K |
| Other Non-Cash Items | -4.63M | 428K | 301K | 451K | 258K | 85K | 218K | -242K | 935K | 232K | 270K | 152K |
| Working Capital Changes | 2.81M | -3M | 199K | 7.73M | -4.92M | -1.5M | -1.93M | -3.23M | 375K | 1.75M | -2.73M | 7K |
| Change in Receivables | 319K | -2.08M | 1.76M | 4.5M | -5.27M | -1.23M | 565K | -1.79M | -250K | 1.15M | -1.1M | -69K |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1K | -416K | -3.77M |
| Change in Payables | -1.72M | 1.31M | 411K | -614K | -188K | -382K | -565K | 1.04M | 222K | -1.22M | 424K | 1.03M |
| Cash from Investing | -14K | -242K | -46K | -253K | -42K | -94K | 0 | 111K | -126K | -153K | -668K | -760K |
| Capital Expenditures | -37K | -242K | -46K | -253K | -42K | -94K | 0 | 111K | -126K | -153K | -668K | -760K |
| CapEx % of Revenue | - | 1.61% | 0.33% | 2.05% | 0.25% | 0.7% | - | 0.79% | 1.05% | 1.32% | 5.32% | 5.81% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 23K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -36K | 168K | -14K | -32K | 0 | 239K | -37K | -145K | 0 | 208K | -590K | -75K |
| Debt Issued (Net) | 0 | -39K | -38K | -38K | -38K | -37K | -37K | -146K | -34K | -74K | 0 | 0 |
| Equity Issued (Net) | 0 | 207K | 24K | 6K | 38K | 276K | 0 | 1K | 0 | -32K | -602K | -75K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -32K | -602K | -74K |
| Other Financing | -36K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34K | 314K | 12K | 0 |
| Net Change in Cash | -1.39M | -1.81M | 540K | 6.58M | 448K | -138K | 274K | -1.85M | -1.04M | 644K | -5.25M | -1.53M |
| Free Cash Flow | -1.38M | -1.98M | 554K | 6.62M | 448K | -377K | 311K | -1.71M | -1.04M | 436K | -4.66M | -1.47M |
| FCF Margin % | - | -13.15% | 3.96% | 53.54% | 2.63% | -2.79% | 2.21% | -12.18% | -8.69% | 3.77% | -37.09% | -11.24% |
| FCF Growth % | -407.14% | -424.4% | 78.14% | 487.98% | 142.87% | -186.47% | 106.68% | -16.07% | -227.59% | -83.74% | -390.94% | -606.55% |
| FCF per Share | -0.10 | -0.14 | 0.04 | 0.48 | 0.03 | -0.03 | 0.02 | -0.13 | -0.08 | 0.03 | -0.34 | -0.11 |
| FCF Conversion (FCF/Net Income) | 4.80x | -5.80x | -1.38x | -3.74x | 0.11x | -0.39x | 0.24x | 16.66x | 0.36x | -0.28x | 1.56x | 0.27x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |